期刊文献+

黏蛋白1在肝内胆管结石合并肝内胆管癌的表达及意义 被引量:1

Expression and significance of MUC1 in hepatolithiasis associated with intrahepatic cholangiocarcinoma
原文传递
导出
摘要 目的探讨肝内胆管结石合并肝内胆管癌组织黏蛋白1(MUC1)的表达及其临床意义。方法选择1989年8月至2009年6月手术切除肝组织石蜡标本90例,肝内胆管结石合并肝内胆管癌33例为实验组,肝内胆管结石32例为对照组,肝脏良性肿瘤瘤旁1~2cm正常肝内胆管组织25例为空白组。各取组织切片进行MUC1免疫组化染色,分析其表达差异及意义。结果 MUC1在实验组、对照组及空白组的阳性率分别为54.5%(18/33)、28.1%(9/32)和0(0/25),3组间比较,P<0.01;MUC1阳性表达在病理组织学分级、淋巴结转移的差异均有统计学意义(P分别<0.05,<0.01);肿瘤患者MUC1阳性表达者的累积生存率比阴性表达者低(P<0.01)。结论 MUC1在肝内胆管结石发展为胆管癌过程中可能起重要作用,MUC1高表达与肝内胆管结石合并肝内胆管癌的恶性程度以及预后有关。 Objective To investigate the role of MUC1 in hepatolithiasis associated with intrahepatic cholangiocarcinoma.Methods Ninety cases biopsies of hepatectomies performed from August 1989 to June 2009 in the second affiliated hospital of Sun Yat-sen university were stained immunohistochemically for MUC1.Among them 33 cases with hepatolithiasis associated with intraheptic cholangiocarcinoma were experimental group, 32 cases with hepatolithiasis were control group and 25 cases of normal intrahepatic bile ducts were taken 1-2 cm distal to benign hepatic neoplasm as blank group.The immunohistochemical staining of MUC1 were performed by tissues slice.Results MUC1 positive rate were 54.5%(18/33), 28.1%(9/32) and 0 (0/25) in experimental group,control group and blank group respectively, P〈0.01.The positive rates were significantly different in experimental group among histopathologic classification (P〈0.05) and whether with lymph node metastasis or not (P〈0.01).The accumulated survival rate was lower in MUC1 expressed tumor patients than that in MUC1 non-expressed tumor patients, P〈0.01.Conclusions MUC1 probably plays an important role during intrahepatic cholangiocarcinogenesis.High level expression of MUC1 is related with malignancy of intrahepatic cholangiocarcinoma and with worse prognosis.
出处 《中华普通外科学文献(电子版)》 2010年第5期16-18,共3页 Chinese Archives of General Surgery(Electronic Edition)
关键词 黏蛋白类 MUC1 肝内 结石 胆管癌 Mucins MUC1 Intrahepati Cholelithiasis Cholangiocarcinoma
  • 相关文献

参考文献9

  • 1Singh R,Bandyopadhyay D.MUC1:a target molecule for cancer therapy.Cancer Biol Ther,2007,6(4):481-486.
  • 2Tinder TL,Subramani DB,Basu GD,et al.J Immunol,2008,181(5):3116-3125.
  • 3陈汝福,李志花,苏红,周泉波,林青,王捷,陈积圣.肝内胆管结石合并肝胆管癌:附24例报告[J].中国普通外科杂志,2006,15(3):170-172. 被引量:14
  • 4Huang L,Chen D,Liu D,et al.MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.Cancer Res,2005,65(22):10413-10422.
  • 5Yuan Z,Wong S,Borrelli A,et al.Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.Biochem Biophys Res Commun,2007,362(3):740-746.
  • 6Lillehoj EP,Lu W,Kiser T,et al.MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.Biochim Biophys Acta,2007,1773(7):1028-1038.
  • 7张立新,李春海.MUC1粘蛋白的免疫生物学作用及其在肿瘤生物学治疗中的应用[J].中国肿瘤生物治疗杂志,2000,7(3):165-170. 被引量:33
  • 8Zen Y,Sasaki M,Fujii T,et al.Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of bile duct-An immunohistochemical study of 110 cases of hepatolithiasis.J Hepatol,2006,44(2):350-358.
  • 9Acres B,Limacher JM.Muc1 as a target antigen for cancer immunotherapy.Expert Rev Vaccines,2005,4(4):493-502.

二级参考文献9

共引文献45

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部